quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:32:02·233d
INSIDERFiling
Bridge Investment Group Holdings Inc. logo

Chief Accounting Officer Behling Garrett was granted 24,342 shares and returned 69,379 shares to the company, closing all direct ownership in the company (SEC Form 4)

BRDG· Bridge Investment Group Holdings Inc.
Finance
Original source

Companies

  • BRDG
    Bridge Investment Group Holdings Inc.
    Finance

Recent analyst ratings

  • Feb 27UpdateWells Fargo$11.50
  • Jan 7UpdateAnalyst$10.00
  • Nov 8UpdateMorgan Stanley$11.00
  • Oct 14UpdateTD Cowen$10.50
  • Sep 12UpdateWells Fargo$11.00
  • Jan 4UpdateTD Cowen$11.00

Related

  • SEC223d
    SEC Form 15-12G filed by Bridge Investment Group Holdings Inc.
  • SEC228d
    SEC Form EFFECT filed by Bridge Investment Group Holdings Inc.
  • SEC233d
    Amendment: SEC Form SCHEDULE 13D/A filed by Bridge Investment Group Holdings Inc.
  • INSIDER233d
    Vice Chairman Allara Dean returned 6,422,596 units of Class B Common Stock to the company, was granted 48,685 shares and returned 691,885 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER233d
    Director Hopkins Deborah C returned 58,512 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER233d
    Chief Financial Officer Elsnab Katherine was granted 19,474 shares, returned 376,050 shares to the company and returned 56,604 units of Class B Common Stock to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER233d
    Director Leat Chad A returned 57,867 shares to the company, closing all direct ownership in the company (SEC Form 4)
  • INSIDER233d
    Director Chase Debra M returned 47,739 shares to the company, closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022